Daniel Trencher - Jul 17, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: CHIEF STRATEGY OFFICER
Signature: /s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol: TDOC
Transactions as of: Jul 17, 2023
Transactions value $: -$24,660
Form type: 4
Date filed: 7/18/2023, 04:17 PM
Previous filing: Jun 21, 2023
Next filing: Aug 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Sale	-$24.7K	-1K	-4.29%	$24.66	22.3K	Jul 17, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on May 13, 2022.